Introduction {#s1}
============

Surgical management of patients with cingulate epilepsy (CE) is highly challenging, especially in the setting of negative MRI. Due to its mesial and deep location from the cerebral surface as well as the absence of unique ictal manifestations, scalp video-electroencephalography (EEG) may be misleading or non-localizable ([@B1]--[@B4]). The fast propagation of seizure activities originating from cingulate cortex (CC) within the limbic network ([@B5]), complicated functional connectivity between homotopic cingulate and sensorimotor cortex ([@B3], [@B6]), and diffuse bilaterally secondary synchrony of epileptiform discharges from cingulate lesions ([@B2], [@B7]) all contribute to the difficulty in localizing CE.

A confirmed MRI lesion can contribute directly to the identification of the epileptogenic zone (EZ) ([@B8]). When patients have no apparent lesions on the MRI, presurgical evaluation and surgical management can be particularly difficult, as seizure origin could be strongly influenced by the availability of collective expertise and experience in semiology, neurophysiological exploration, and functional imaging interpretation ([@B4], [@B8]). Previous studies with voxel-based MRI post-processing using a morphometric analysis program (MAP) ([@B9]) combined with visual MRI analysis indicated high sensitivity in the identification of subtle epileptic lesions ([@B10]--[@B14]); MAP+ findings was reported to provide valuable targets for invasive evaluation and resection ([@B15]). However, there was no study on the post-processing neuroimaging characteristics of CE with a normal pre-surgical MRI.

In the current study, we aimed to investigate the usefulness of voxel-based MRI post-processing to detect subtle abnormalities in CE with a negative pre-surgical MRI. In relation to the MAP findings, we examined the non-invasive electro-clinical characteristics and functional imaging findings in these patients. When possible, concordance with intracranial EEG finding was investigated.

Materials and methods {#s2}
=====================

Patients
--------

This retrospective study was approved by the institutional review board ethical guidelines of two hospitals: Cleveland Clinic Foundation (CCF) and the Second Affiliated Hospital of Zhejiang University (SAHZU). We reviewed a consecutive series of patients who had surgery at CCF from January 2008 to December 2016 and SAHZU from January 2013 to April 2017. The inclusion criteria were as follows: (1) intracranial-EEG (ICEEG) confirmed focal cingulate ictal onset during recorded habitual seizures, or resection of the cingulate cortex with/without adjacent cortex rendered the patient seizure-free or having marked seizure improvement with 1-year follow-up; (2) preoperative MRI and postoperative MRI/CT data were available; (3) preoperative MRI was considered as negative or suspicious of a subtle lesion during the multidisciplinary patient management conferences (PMC). Patients were excluded if they (1) had poor MRI quality; (2) had a definite lesion in the cingulate cortex on MRI; and (3) seizures recurred without a marked improvement after surgery. The vertical anterior/posterior commissure lines (VAV/VPC) were used as a landmark to divide the cingulate cortex into three parts: the anterior cingulate, located rostral to the VAC; the middle cingulate, located between VAC and VPC; and the posterior cingulate, located caudal to the VPC line ([@B2]).

Presurgical evaluation
----------------------

The surgical strategy was discussed based on pre-surgical evaluation including history, semiology, video scalp-EEG, MRI, FDG-PET, subtraction ictal SPECT co-registered with MRI (SISCOM), Magnetoencephalography (MEG) and ICEEG. Semiology based on history and video-EEG was evaluated with classifications developed by Lüders et al. ([@B16]). Results of pre-surgical evaluation tests were obtained from chart reviews of the patients\' clinical files.

Data acquisition and analyses
-----------------------------

MRI post-processing was based with MAP07 within MATLAB 2015a (MathWorks, Natick, Massachusetts) and analyzed on a voxel basis ([@B9]) with comparison to a normal database consisting of 90 normal controls ([@B17]). Patients from CCF were scanned by 3.0-T MRI scanners (Trio or Skyra, SIEMENS, Erlangen, Germany) with T1-weighted Magnetization Prepared Rapid Acquisition with Gradient Echo images; patients from SAHZU were scanned with a 3.0-T MRI scanner (MR750, GE Healthcare) with a 3-dimensional (3D) T1-weighted Spoiled Gradient Recalled Echo sequence. Detailed parameters can be found elsewhere ([@B18]). The final outputs of MAP consisted of three feature maps, the *junction, extension*, and *thickness* maps. The *junction* map is sensitive to blurring of the gray-white matter junction; the *extension* map is sensitive to abnormal gyration and extension of gray matter into white matter; the *thickness* map is sensitive to abnormal cortical thickness ([@B9]). A blinded reviewer (Shan Wang) used a z-score threshold of 3 to identify candidate MAP+ regions in the junction file and then examined the suspect on extension (Z\>6) and thickness (Z\>4) files. The abnormality was reaffirmed by a neuroradiologist (SEJ), checking pre-operative MRI including T1-weighted, T2-weighted and FLAIR sequences to confirm MAP+ positive regions. In all MAP+ patients, we used SPM12 to co-register preoperative T1-weighted images, MAP files and postoperative MRI images in order to confirm whether the location of the MAP+ regions was included in the resection.

Pathology and outcome
---------------------

Surgical pathology, when available, was re-reviewed by dedicated neuropathologists from each hospital. The diagnosis and classification of FCD were performed according to the ILAE guidelines ([@B19]). Postoperative seizure outcomes were determined according to Engel\'s Classification ([@B8]). Engel Class 1 (seizure-free) and 2 (\>90% reduction) were regarded as marked improvement of seizure frequency ([@B2], [@B8]).

Results {#s3}
=======

Patient population
------------------

Out of the 1,518 patients with a localized resection from the CCF surgical database, 21 patients had resection of the cingulate cortex; 17 of the 21 patients had strictly non-lesional MRI or had subtle cingulate abnormalities. Ten patients were further excluded because the invasive EEG onset was not merely limited to the cingulate region, or the resection included but extended beyond the cingulate cortex, or there was no marked seizure improvement after surgery. Out of the 240 patients with a localized resection from SAHZU, 7 patients had resection of the cingulate cortex; 3 patients had strictly non-lesional MRI. One patient was further excluded because the invasive EEG onset was not merely limited to the cingulate cortex. Therefore, a total of 9 patients were identified from the two Epilepsy Centers (7 from CCF), including 5 from anterior CE, 3 from middle CE and 1 from posterior CE. Six were females; the median age at surgery was 22 (range, 14.5--38) years; the median epilepsy duration was 60 (range, 13--173) months. Six patients with negative MRI underwent ICEEG monitoring, which confirmed cingulate focal ictal onset during their habitual seizures. Subtle CC abnormalities in three patients were identified during re-review at PMC and no ICEEG was recommended per PMC consensus for these 3 patients. Detailed clinical information, results of pre-surgical evaluation, pathology, and postsurgical seizure outcomes were summarized in Table [1](#T1){ref-type="table"}.

###### 

Summary of clinical profile, presurgical evaluation data, surgery, histopathology, and postoperative seizure outcome for the 9 included patients.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Parameters/No**.                **P1**                                                  **P2**                            **P3**                                                                  **P4**                                                        **P5**                                     **P6**                           **P7**                                              **P8**                                            **P9**
  --------------------------------- ------------------------------------------------------- --------------------------------- ----------------------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------ -------------------------------- --------------------------------------------------- ------------------------------------------------- -------------------------
  Age range (Y)                     26--30                                                  11--15                            16--20                                                                  11--15                                                        31--35                                     21--25                           41--45                                              41--45                                            21--25

  Handedness                        R                                                       R                                 L                                                                       R                                                             R                                          R                                R                                                   L                                                 R

  Epilepsy duration (m)             60                                                      14                                108                                                                     130                                                           4                                          12                               300                                                 216                                               24

  Seizure semiology                 Dialeptic → hypomotor /gelastic sz                      Complex motor sz                  Aura (L hand somatosensory) → bil asymmetric tonic → L hand clonic sz   Aura (dizziness) → bil asymmetric tonic sz → R arm tonic sz   Aura (fear) → automotor/complex motor sz   Aura (fear) → Complex motor sz   Aura (L arm somatosensory) → automotor sz → sGTCS   Unclassified aura → hypermotor/complex motor sz   Complex motor sz

  Ictal scalp EEG                   L\                                                      L\                                Non-localized                                                           L\                                                            R anterior mesial frontal                  L\                               R temporal                                          Non-localized                                     Bil Central
                                    fronto-centro-parietal                                  central                                                                                                   frontal                                                                                                  hemisphere                                                                                                                             

  Invasive interictal EEG           L\                                                      L\                                R MCG                                                                   NA                                                            NA                                         NA                               R PCG/hippocampus                                   L\                                                L\
                                    ACG/MCG/superior-middle frontal/precentral              MCG                                                                                                                                                                                                                                                                                                     MCG                                               ACG/mesial frontal

  Invasive ictal EEG                L\                                                      L\                                R MCG                                                                   NA                                                            NA                                         NA                               R PCG                                               L\                                                L\
                                    ACG/MCG                                                 MCG                                                                                                                                                                                                                                                                                                     MCG                                               ACG

  MAP                               L\                                                      L\                                R MCG                                                                   L\                                                            R ACG                                      L\                               Neg                                                 Neg                                               Neg
                                    ACG                                                     MCG                                                                                                       ACG                                                                                                      ACG                                                                                                                                    

  FDG-PET                           L\                                                      R parietal                        Bil temporal; frontal operculum/insular, L\>R                           L\                                                            Bil temporal/dorsal medial frontal         L\                               R fronto-temporal                                   Bil parieto-temporal, L\>R; left frontal          L\
                                    dorsomedial frontal                                                                                                                                               fronto-temporal                                                                                          temporal                                                                                                                               anterior mesial frontal

  SISCOM (injection time/seconds)   L\                                                      N/A                               Bil dorsal posterior frontal; R occipital ([@B16])                      R dorsal parietal/mid-posterior lateral temporal ([@B15])     NA                                         NA                               NA                                                  R fronto-temporal ([@B12])                        NA
                                    fronto-parieto-occipital ([@B14])                                                                                                                                                                                                                                                                                                                                                                                 

  MEG                               L\                                                      L\                                Bil Central                                                             NA                                                            NA                                         NA                               Bil temporal                                        Neg                                               NA
                                    superior/middle frontal                                 fronto-central (outside report)                                                                                                                                                                                                                                                                                                                           

  Pathology                         Surgery 1: NA (laser) Surgery 2: Infarct/inflammation   NA (laser)                        FCD IIb                                                                 FCD IIb                                                       FCD IIb                                    FCD IIa                          FCD Ib                                              FCD Ib                                            FCD IIa

  Surgery                           L\                                                      L\                                R MCG resection                                                         L\                                                            R ACG resection                            L\                               R PCG resection                                     L\                                                L\
                                    ACG laser L ACG + superior frontal resection            MCG laser                                                                                                 ACG resection                                                                                            ACG resection                                                                        MCG resection                                     ACG resection

  Outcome                           Surgery 1: II Surgery 2: IA                             II                                IA                                                                      IA                                                            IA                                         IA                               IB                                                  IB                                                IA
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*y, year; m, months; M, male; F, female; R, right; L, left; Bil, bilateral; sz, seizures; sGTCS, secondary generalized tonic clonic seizures; NA, not available; ACG, anterior cingulate gyrus; MCG, mid cingulate gyrus; PCG, posterior cingulate gyrus; Neg, negative*.

Non-invasive pre-surgical evaluation
------------------------------------

On scalp EEG, ictal onset lateralized to the ipsilateral hemisphere (fronto-centro-parietal = 1, central = 1, frontal = 2, temporal = 1, hemisphere = 1) in 6 of the 9 patients. FDG-PET was performed in all 9 patients; in only 2 patients, hypometabolism overlapped with (and also extended beyond) the CC (P1 and P9). Ictal SPECT was successfully obtained in 4 of the 9 patients (injection time: 12--16 s); the hyperperfusion areas contained the CC only in one patient (P1). MEG was performed in 5 of the 9 patients; positive findings were found in 4 patients, and only 2 of the 4 patients had MEG findings overlapping with the CC (P1 and P2, both loose clusters).

MAP findings
------------

The MAP findings are illustrated for all 9 patients in Figure [1](#F1){ref-type="fig"}. Single MAP+ abnormalities were found in 6 patients (P1-P6), including 3 of the 6 patients with negative MRI, and 3 patients with subtly lesional MRI. In P1-P3 who had negative MRI, MAP gray-white junction file pinpointed a subtle abnormality in the anterior or middle CC, which was found in retrospect to represent subtle blurring of gray-white matter junction in the original T1/FLAIR images, concordant with ICEEG (Figure [1](#F1){ref-type="fig"}). P4-P6 with subtly lesional MRI were all found to have abnormalities on MAP in the anterior CC; they did not have ICEEG as the subtle findings were identified during re-review at PMC. P7-P9 had negative MAP while their ICEEG showed focal ictal onset in the cingulate cortex. MAP extension or thickness files did not have additional yield; only in P4, a supra-threshold abnormality was seen on the extension file accompanying the junction file.

![MAP findings illustrated for all 9 patients included in this study. Single MAP+ abnormalities were found in 6 patients (P1-P6), including P1-P3 who had negative 3T MRI by visual analyses, and P4-P6 who had subtly lesional 3T MRI by visual analyses. P7-P9 had negative MAP. First column: pre-surgical T1-weighted/FLAIR images; second column: co-registered MAP junction files; third column: post-surgical MRI indicating resection of the cingulate cortex. The red circle or cross hair shows the location of subtle abnormalities identified by MAP (in P7-P9, MAP was negative so the crosshair was set to the location of the ICEEG ictal onset). Fourth column shows ICEEG ictal onset and FDG-PET/SISCOM/MEG findings (if concordant). Red electrode contacts indicate ictal onset locations that are concordant with MAP+ findings. In P1, two surgeries were performed, 25 months apart. P1 had seizure recurrence at 15 months following laser ablation that partially overlapped with the MAP+ abnormality, and became seizure-free for 1 year after the second resection to clean up the resection margin, which included the entire MAP+ region.](fneur-09-01013-g0001){#F1}

Outcome, surgery, and pathology
-------------------------------

Out of the 6 MAP+ patients, 4 patients (P3-P6) had the resection completely overlapping with the MAP+ region and became seizure-free; two patients (P1 and P2) didn\'t become seizure-free: P1 experienced seizure recurrence at 15 months following laser ablation that partially overlapped with the MAP+ abnormality, and became seizure-free for 1 year after the second resection to clean up the resection margin, which included the entire MAP+ region; in P2, who had marked improvement in seizure frequency and intensity (Class II), post-operative MRI indicated incomplete removal of the area corresponding to ICEEG and MAP. The 3 MAP-negative patients did become seizure-free (one Class Ia, two Class Ib) following resective surgery guided by ICEEG. Surgical pathology revealed FCD in 7 patients, including FCD type Ib (*n* = 2), type IIa (*n* = 2), and type IIb (*n* = 3). No specimen was sent to pathology examination in the two patients who had laser ablation.

Discussion {#s4}
==========

Non-lesional cingulate epilepsy is a rare form of epilepsy ([@B2]). Our current study presents the largest series of patients with surgically confirmed non-lesional cingulate epilepsy, with utility of MRI postprocessing to help identify subtle structural abnormalities in this challenging cohort. We showed that voxel-based MRI postprocessing identified subtle epileptic abnormalities in the majority of patients, while the localization value of scalp EEG, PET, ictal SPECT, and MEG was relatively limited. This finding emphasizes the practical value of adding MRI post-processing into the presurgical evaluation workflow of MRI-negative cingulate epilepsy.

Surgical management of patients with CE is challenging, as CE exhibits significant heterogeneity in its manifestations due to different seizure propagation patterns ([@B3]). Animal and human studies have demonstrated that the anterior CC is bi-directionally connected to the prefrontal and premotor areas, and the posterior CC bi-directionally connected to the mesial temporal regions ([@B1], [@B3], [@B20], [@B21]). Moreover, epileptic discharges from the CC often present secondary bilateral synchronous epileptiform discharges, which increases the difficulty to precisely localize ([@B22]). Not surprisingly, scalp EEG was less helpful to localize EZ located in the CC because of its low spatial resolution and inability to detect deep focus ([@B3]). Complex epileptic networks and fast propagation of discharges from the CC could account for the relatively low yields of PET and SISCOM as reported in previous studies ([@B1], [@B2], [@B12], [@B23]). Wong et al. ([@B24]). demonstrated that rapid spread of epileptic activities could result in widespread hypometabolism, sometimes remote to the EZ. Diffuse regions of hyperperfusion might reflect the epileptic network which includes the epileptic focus as well as the propagation pathways away from the onset, further complicating the task of localization ([@B25]). Although MEG has theoretical advantages including high spatial and temporal resolution in identifying epileptic activities from deep structures compared to scalp EEG ([@B26]), its localization seemed to be limited for CC as shown in our study, perhaps due to the CC producing radially oriented sources difficult to be detected by MEG source localization.

In 50% (3 of 6) of the patients with CE and negative MRI in our series, abnormalities were identified using MAP; in all 3 patients with CE and subtly lesional MRI, abnormalities were identified using MAP; the overall detection rate was analogous to published series whose detection rate ranged between 43 and 50% in MRI-negative epilepsies ([@B12], [@B13]). FCD is the most common identifiable pathology among MRI-negative epilepsies, frequently presenting blurring of the gray-white matter junction ([@B11]). Therefore, it is expected that junction map was the most helpful feature map in the current study and previous studies ([@B11]--[@B13]). The majority (4 of 5) patients with FCD type II were successfully detected by MAP in our study, while neither case with FCD type I (P7-P8) was MAP+. Therefore, the type of the underlying pathology likely contributes to the negative MAP results. It\'s a considerable challenge to identify and demarcate FCD type I by current MRI techniques even in patients with confirmed histopathology ([@B27]), as FCD type I is typically not as well-characterized on the MRI with less prominent features. Our previous study looked at a group of 150 MRI-negative epilepsies which mostly consisted of FCD type I; not all patients with positive pathology of FCD type I were MAP+; additionally, 5 patients with FCD type I had seizure recurrence even though resection fully overlapped with their MAP+ regions, which suggests insufficient delineation of the full extent of the FCD type I using the current technique ([@B13]). Another point worth noting is that the T1-based MAP processing, as utilized in this study, would not be able to capture subtle FCDs with a strong T2 change but no T1 change. This could be another factor contributing to negative MAP results. In the face of a completely non-lesional MRI (visual-negative and MAP-negative), ICEEG is often mandatory to explore the epileptogenic zone.

Being seizure-free is the gold standard to identify epileptogenic characteristics of MAP+ changes ([@B11], [@B12]). In the current study, MAP+ findings were included in the surgical resection in 4 patients with seizure freedom, suggesting that these findings were true positive findings. The two patients who didn\'t become seizure-free both had laser ablation which partially overlapped with their MAP+ abnormalities; the less optimal seizure outcomes might be due to the incomplete removal of the epileptic structural abnormality. The type of surgery could also be contributive; although minimally invasive, laser ablation was reported to be less effective than conventional resective surgery in a prior study on 19 pediatric patients ([@B28]).

Limitations {#s5}
===========

Patients studied here were a highly selected cohort and could not represent all patients with cingulate epilepsy. Using a combined dataset from two epilepsy centers, there might have been differences in the interpretation of presurgical evaluation tests and surgical decision. These limitations should be considered when interpreting results from our study.

Conclusion {#s6}
==========

Surgical management of patients with cingulate epilepsy is highly challenging, particularly when the MRI is negative. The localizing yield of non-invasive tests such as scalp EEG, PET, ictal SPECT and MEG in non-lesional cingulate epilepsy is relatively limited and ICEEG is often mandatory. MRI postprocessing could be incorporated into routine surgical evaluation to enhance detection of subtle epileptogenic abnormalities in this particularly challenging population.
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